IgA nephropathy: a stem cell disease?

Despite intensive investigation by several groups, a widely accepted hypothesis for the pathogenesis of immunoglobulin A (IgA) nephropathy has not yet emerged.

[1]  T. Ohno,et al.  Bone marrow transplantation attenuates murine IgA nephropathy: Role of a stem cell disorder1 , 1999 .

[2]  Bin Wang,et al.  Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Kincaid‐smith.  Treatment of mesangial immunoglobulin A glomerulonephritis. , 1999, Seminars in nephrology.

[4]  T. Imasawa,et al.  Evidence suggesting the involvement of hematopoietic stem cells in the pathogenesis of IgA nephropathy. , 1998, Biochemical and biophysical research communications.

[5]  S. Ikehara.  Bone Marrow Transplantation for Autoimmune Diseases , 1998, Acta Haematologica.

[6]  G. Remuzzi.  Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  A. Marmont.  Stem cell transplantation for severe autoimmune diseases: progress and problems. , 1998, Haematologica.

[8]  B. Julian,et al.  Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. , 1997, Kidney international.

[9]  J. Galla.  IgA nephropathy. , 1995, Kidney international.

[10]  M. Daha,et al.  Pathogenesis of IgA nephropathy , 1992 .